Effect of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) on Lipid Particles in Type 2 Diabetes Mellitus (T2DM)

被引：0

|

作者：

Jones, Michael R.

Ford, Daniel M.

Baz-Hecht, Merav

Tao, Ben

Truitt, Kenneth E.

Chou, Hubert S.

机构：

来源：

DIABETES | 2013年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1161-P

引用

收藏

页码：A302 / A302

页数：1

相关论文

共 50 条

[21] Efficacy and Safety of Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM) on Metformin (MET) and Pioglitazone (PIO) Over 52 Weeks
Forst, Thomas
Guthrie, Robert
Goldenberg, Ronald
Yee, Jacqueline
Vijapurkar, Ujjwala
Meininger, Gary
Stein, Peter
[J]. DIABETES, 2013, 62 : A284 - A284
[22] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
Du, Jin
Liang, Li
Fang, Hui
Xu, Fengmei
Li, Wei
Shen, Liya
Mu, Yiming
[J]. DIABETES, 2016, 65 : A293 - A293
[23] Impact of baseline gastric emptying on effects of lixisenatide and liraglutide in type 2 diabetes mellitus (T2DM) as add-on to insulin glargine
Menge, B. A.
Kapitza, C.
Hincelin-Mery, A.
Roy-Duval, C.
Delfolie, A.
Coester, H. -V.
Forst, T.
Meier, J. J.
[J]. DIABETOLOGIA, 2014, 57 : S38 - S38
[24] GlyCemic Control with Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
Fu, Alex Z.
Qiu, Ying
Radican, Larry
[J]. DIABETES, 2010, 59 : A612 - A613
[25] Efficacy of Teneligliptin as a Fourth Add-On in Patients with Type 2 Diabetes Mellitus (T2DM) Poorly Controlled on Triple Drug Therapy
Panikar, Vijay
Joshi, Shashank R.
Vadgama, Jimit
Kamat, Tejas
Nasikkar, Nikhil
Deogaonkar, Narayan
Jain, Chandni
[J]. DIABETES, 2017, 66 : A340 - A340
[26] Pioglitazone (PIO) improves glycemic control in drug-therapy naive patients with type 2 diabetes (T2DM)
Herz, M
Tan, M
Johns, D
Robertson, KE
Gonzalez, B
Reviriego, J
Grossman, L
[J]. DIABETES, 2002, 51 : A481 - A481
[27] Pioglitazone (PIO) improves atherogenic dyslipidemia in drug-therapy naive patients with type 2 diabetes (T2DM)
Tan, MH
Herz, M
Johns, D
Robertson, KE
Gonzalez, B
Reviriego, J
Grossman, LD
[J]. DIABETES, 2002, 51 : A497 - A497
[28] Add-on to metformin in T2DM—linagliptin or glimepiride?
Mikkel Christensen
Filip K. Knop
[J]. Nature Reviews Endocrinology, 2012, 8 : 576 - 578
[29] Saxagliptin vs Glipizide as Add-On Therapy to Metformin for Type 2 Diabetes Mellitus (T2DM): Long-Term Safety and Efficacy
Goeke, Burkhard
Gallwitz, Baptist
Eriksson, Johan
Bokelund-Singh, Sara
Gause-Nilsson, Ingrid
[J]. DIABETES, 2011, 60 : A305 - A305
[30] Patient Characteristics Associated with Add-On Medication Treatment for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
Qiu, Ying
Fu, Alex Z.
Radican, Larry
[J]. DIABETES, 2010, 59 : A604 - A604

← 1 2 3 4 5 →